1.1. Glynne-Jones R, Northover J, Oliveira J. ESMO Guidelines Working Group. Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl. 4): 57-60.2.2. Frisch M, Glimelius B, van den Brule AJ et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.3.3. Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007; 12: 524-34.4.4. Ortholan C, Ramaioli A, Peiffert D et al. Anal canal carcinoma: early - stage tumors ≤10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 479-85.5.5. Das P, Crane C, Ajani J. Current treatment of localized anal carcinoma. Curr Opin Oncol 2007; 19: 396-400.6.6. Buchs NC, Allal AS, Morel P, Gervaz P. Prevention, chemoradiation and surgery for anal cancer. Expert Rev Anticancer Ther 2009; 9: 483-9.7.7. Conroy T, Ducreux M, Lemanski C et al. Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 trial (abstract). J Clin Oncol 2009; 27 (Suppl. 15 s): 4033.8.8. Zilli T, Schick U, Ozsahin M et al. Node-negative T1-T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy? Radiother Oncol 2011.9.9. Graf R, Wust P, Hildebrandt B et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003; 65: 14-22.10.10. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008; 299: 1914-21.11.11. Вazan JG, Hara W, Hsu A et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer 2011; 117: 3342.12.12. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 2008; 299: 1914-21.13.13. Van Damme N, Deron P, Van Roy N et al. Epidermal growth factor receptor and K-RAS stasus in two cohorts of squamous cell carcinomas. BMC Cancer 2010; 10: 189.14.14. Zampino MG, Magni E, Sonzogni A, Renne G. K-Ras status in squamous cell anal carcinoma (SCC): it's time for target oriented treatment? Cancer Chemother Pharmacol 2009; 65:197-9.